Analysis of Reported Adverse Events with Uterine Artery Embolization for Leiomyomas
The Manufacturer and User Facility Device Experience (MAUDE) database may be useful for clinicians using a Food and Drug Administration-approved medical device to identify the occurrence of adverse events and complications. We sought to analyze and investigate reports associated with uterine artery embolization used for treatment of fibroids using this database.
Source: The Journal of Minimally Invasive Gynecology - Category: OBGYN Authors: Abigail A Armstrong, Lindsay Kroener, Meredith Brower, Zain A Al-Safi Tags: Original Article Source Type: research
More News: Databases & Libraries | Food and Drug Administration (FDA) | Leiomyoma | Medical Devices | OBGYN